Monday, April 28, 2025 | 10:36 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch
Sensex (    %)
                             
Nifty (    %)
                             
Nifty Midcap (    %)
                             
Nifty Smallcap (    %)
                             
Nifty Bank (    %)
                             
Nifty IT (    %)
                             
Home / Markets / Aurobindo Pharma Ltd / Announcements / BSE

Aurobindo Pharma Ltd

Curateq Biologics Received Marketing Authorization For Dyrupeg™ A Pegylated Filgrastim Biosimilar

02:31 PM, 5th Apr 2025

Intimation of receipt of Marketing authorisation by Curateq Biologics s.r.o a wholly owned step down subsidiary of the Company.

More Aurobindo Pharma Ltd Announcements

    View more
    Business Standard
    HOT STOCKS
    TOP SECTIONS
    KEY EVENTS
    Copyrights © 2025 Business Standard Private Ltd. All rights reserved
    LinkedIN Icon